Week 1 of the fellowship is in the books. I’m extremely excited to be part of this incredible program and team of fellows. @MayoCVFellows @MayoClinic #CardioTwitter #MedTwitter

Contratulations @HamandiMd for this important contribution! MAC with mitral valve dysfunction and tricuspid regurgitation often coexist. It's important to study this as we enter the commercial era for TMVR in MAC with already 1 TMVR device (Tendyne) FDA approved for patients with

Grateful for an incredible experience at #TCT2025 — from presenting our latest research to connecting with mentors and catching up with friends. Huge thanks to @TCTMD @crfheart @MayoClinicCV @MayoCVFellows

Once the forgotten, tricuspid valve is now the center of attention. TR is the most prevalent valvular heart disease among U.S. adults aged 65 to 85 years. #TCT2025 #PREVUEVALVE

@MayoClinicCV @MayoCVFellows @MayraGuerreroMD @pattypellikka @AbdullahAlabcha Here are the slides with more details. @MayraGuerreroMD

Presented our study on the prognostic impact of tricuspid regurgitation in patients with mitral annular calcification at TCT in San Francisco. Thanks Dr Guerrero and Dr Pellikka for your mentorship and support. @MayoClinicCV @MayoCVFellows @MayraGuerreroMD @pattypellikka

The movers & the shakers.. #TCTPlusMiddleEast team at the Moscone center preparing for the second iteration of the conference #InnovateDontReplicate Stay tuned for updates due for release this November @crfheart @TCTConference @jgranadacrf @djc795 @drptca @Dr_HaniNajm

@Hragy @realarainmd @ziadalinyc @mmamas1973 @ColletCarlos @GreggWStone The best way to reduce atherosclerotic risk related to high TG is to get apoB to control (<70 mg/dL). Once that is done if TG are still high (> 500 mg/dL - pancreatitis risk) add high dose (4 gm) of omega 3 product or use fenofibrate if renal function is OK and patient not on

A striking example of double-site obstruction in hypertrophic cardiomyopathy. The apical view demonstrates color Doppler flow acceleration in the LVOT with systolic anterior motion of the mitral valve during Valsalva. The CW Doppler reveals two distinct peaks — the first

LBBB EKG criteria include the absence of Q waves in leads I, V5, and V6. This helps distinguish true LBBB from a nonspecific intraventricular conduction delay. The loss of septal Q waves occurs because normal left-to-right septal depolarization is disrupted by the conduction

#CardioX #cardiotwitter #EPeeps

VT storm is defined as ≥3 sustained VT episodes in 24 hours, each requiring termination. First-line: Correct reversible triggers—electrolyte abnormalities (Mg, K, Ca; hypokalemia most common) and ischemia. Administer IV amiodarone and IV propranolol. If an ICD is present,

Cardiogenic shock in Takotsubo can result from myocardial stunning or dynamic LVOT obstruction. Be cautious with inotropes—they can worsen obstruction and hypotension. Volume (if tolerated) may help. #FellowTips #CardioX @benhibbertMDPhD

Grateful for the amazing nurses, fellows, and consultants who made this rotation such a meaningful part of training. @MayoCVFellows @nandananavekar

I just wrapped up my month in the CICU, what an incredible experience. It was a month filled with complex cases, procedures, and nonstop learning. I placed 12 Swans, 18 art lines, 6 TL/HD catheters, 1 TVP, countless TTEs and finished the month by placing an IABP with @TDonisan

Selfies ..impressive 450 faculty attending the inaugural @TCT_ME_ meeting Riyadh from all 5 continents 🫶😁 @baileyannRN 🇺🇸 @Sudanheartgroup 🇸🇩 @6ayyeboon 🇰🇼 @DrMohammedSobh2 🇪🇬 Stage managers & @crfheart directors @kalazizimd @MarwanSaadMD @djc795 @jgranadacrf

We presented our results at TCT Middle East in Riyadh, Saudi Arabia @TCT_ME_ Thanks to the project leads for the support @AbdullahAlabcha @adnanalkhouli @MayoCVFellows @MayoClinicCV

Excellent evening program at TCT Middle East: Women’s Cardiovascular Research Consortium. @TCT_ME_

Shark Tank Innovation Competition at TCT Middle East. @adnanalkhouli is presenting the Cryo X thrombus removal platform. @MayoClinicCV @MayoCVFellows @TCT_ME_

Our own @adnanalkhouli presenting at TCT Middle East in Riyadh, Saudi Arabia on the early experience with Adona device. @MayoClinicCV @MayoCVFellows @TCT_ME_

It was a tremendous pleasure serving as @FITsOnTheGo Co-Director at #ACC25 alongside these wonderful humans and colleagues. Grateful for the chance to meet and connect with trialists and trainees from around the world. Thanks @MayoCVFellows for this great opportunity.